In a joint effort to provide customers with one of the most advanced solutions for molecular testing, Siemens Healthcare and Thermo Fisher Scientific announce a new strategic relationship that includes the integration of Thermo Fisher Scientific's real-time PCR system into Siemens' VERSANT kPCR Molecular Solution.

The combined workflow will offer laboratories Siemens' complete molecular testing solution, which helps ensure leading-edge performance from extraction through detection. Siemens displayed the entire system during the European Congress of Clinical Microbiology and Infectious Disease in Amsterdam, The Netherlands, April 9-12.

Thermo Fisher has brought to market easy-to-use, real-time PCR instruments. Designed for mid-throughput, these new systems provide ideal solutions for all users who need a high-performance instrument with features for maximum experiment control. Adding Thermo Fisher's real-time PCR system to the VERSANT kPCR Molecular Solution brings a new level of innovation to the market by providing more flexibility and customization to the molecular laboratory workflow.

"Through our molecular diagnostics systems, we offer a total solution for accurate diagnosis and monitoring," says Mr Fernando Beils, Head of Molecular Diagnostics, Siemens Healthcare. "We are excited to strengthen our dedication to molecular laboratory innovations through our partnership with Thermo Fisher Scientific."

"This agreement underscores our commitment to work with leading molecular diagnostic organizations that share our vision to develop advanced laboratory solutions," said Mr Drew Burch, Head of Licensing and Commercial Supply for Thermo Fisher Scientific. "We are excited to collaborate with Siemens in support of its VERSANT kPCR Molecular Solution as we work to expand our partnerships in the diagnostics space."